Vivien Hsu

14.8k total citations
43 papers, 2.1k citations indexed

About

Vivien Hsu is a scholar working on Pathology and Forensic Medicine, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Vivien Hsu has authored 43 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Pathology and Forensic Medicine, 14 papers in Epidemiology and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Vivien Hsu's work include Systemic Sclerosis and Related Diseases (28 papers), Inflammatory Myopathies and Dermatomyositis (12 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (9 papers). Vivien Hsu is often cited by papers focused on Systemic Sclerosis and Related Diseases (28 papers), Inflammatory Myopathies and Dermatomyositis (12 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (9 papers). Vivien Hsu collaborates with scholars based in United States, United Kingdom and Australia. Vivien Hsu's co-authors include James R. Seibold, Maureen D. Mayes, Peter A. Merkel, Daniel E. Furst, Dinesh Khanna, Joseph H. Korn, Virginia Steen, Ariane L. Herrick, Christopher P. Denton and Robert W. Simms and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Internal Medicine and Annals of the Rheumatic Diseases.

In The Last Decade

Vivien Hsu

43 papers receiving 2.0k citations

Peers

Vivien Hsu
Vivien Hsu
Citations per year, relative to Vivien Hsu Vivien Hsu (= 1×) peers Silvia Bellando-Randone

Countries citing papers authored by Vivien Hsu

Since Specialization
Citations

This map shows the geographic impact of Vivien Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vivien Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vivien Hsu more than expected).

Fields of papers citing papers by Vivien Hsu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vivien Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vivien Hsu. The network helps show where Vivien Hsu may publish in the future.

Co-authorship network of co-authors of Vivien Hsu

This figure shows the co-authorship network connecting the top 25 collaborators of Vivien Hsu. A scholar is included among the top collaborators of Vivien Hsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vivien Hsu. Vivien Hsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hsu, Vivien, et al.. (2024). Successful Treatment of Candida auris Ventriculitis With Intravenous Liposomal Amphotericin B and Oral Flucytosine: A Case Report. Open Forum Infectious Diseases. 12(1). ofae743–ofae743. 1 indexed citations
2.
Saketkoo, Lesley Ann, Jessica Gordon, Kim Fligelstone, et al.. (2023). Patient Experience of Systemic Sclerosis–Related Calcinosis. Rheumatic Disease Clinics of North America. 49(2). 463–481. 2 indexed citations
3.
Ng, Zi Qin, et al.. (2023). Predictors for success of non-operative management of adhesive small bowel obstruction. World Journal of Gastrointestinal Surgery. 15(6). 1116–1124. 5 indexed citations
4.
Khanna, Dinesh, Paul H. Caldron, Richard W. Martin, et al.. (2022). Adipose‐Derived Regenerative Cell Transplantation for the Treatment of Hand Dysfunction in Systemic Sclerosis: A Randomized Clinical Trial. Arthritis & Rheumatology. 74(8). 1399–1408. 20 indexed citations
5.
Spiera, Robert, Laura K. Hummers, Leland W.K. Chung, et al.. (2020). Safety and Efficacy of Lenabasum in a Phase II, Randomized, Placebo‐Controlled Trial in Adults With Systemic Sclerosis. Arthritis & Rheumatology. 72(8). 1350–1360. 72 indexed citations
6.
Valenzuela, Antonia, Murray Baron, Tatiana Sofia Rodrı́guez-Reyna, et al.. (2020). Calcinosis is associated with ischemic manifestations and increased disability in patients with systemic sclerosis. Seminars in Arthritis and Rheumatism. 50(5). 891–896. 33 indexed citations
7.
Baisre, Ada, et al.. (2018). Case of Anti–Single Recognition Particle–Mediated Necrotizing Myopathy After Influenza Vaccination. Journal of Clinical Neuromuscular Disease. 19(4). 211–216. 8 indexed citations
8.
Hsu, Vivien, Christopher P. Denton, Robyn T. Domsic, et al.. (2017). Pomalidomide in Patients with Interstitial Lung Disease due to Systemic Sclerosis: A Phase II, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study. The Journal of Rheumatology. 45(3). 405–410. 29 indexed citations
9.
Schiopu, Elena, Soumya Chatterjee, Vivien Hsu, et al.. (2016). Safety and tolerability of an anti-CD19 monoclonal antibody, MEDI-551, in subjects with systemic sclerosis: a phase I, randomized, placebo-controlled, escalating single-dose study. Arthritis Research & Therapy. 18(1). 131–131. 60 indexed citations
10.
Valenzuela, Antonia, Murray Baron, Ariane L. Herrick, et al.. (2016). Calcinosis is associated with digital ulcers and osteoporosis in patients with systemic sclerosis: A Scleroderma Clinical Trials Consortium study. Seminars in Arthritis and Rheumatism. 46(3). 344–349. 58 indexed citations
11.
Hsu, Vivien, et al.. (2015). Dual-energy Computed Tomography for the Evaluation of Calcinosis in Systemic Sclerosis. The Journal of Rheumatology. 42(2). 345–346. 7 indexed citations
12.
Schiopu, Elena, Vivien Hsu, & Ann Impens. (2010). Randomized Placebo-Controlled Crossover Trial of Tadalafil in Raynaud's Phenomenon Secondary to Systemic Sclerosis. Journal of Vascular Surgery. 52(2). 519–519. 4 indexed citations
13.
Matucci‐Cerinic, Marco, CP Denton, D.E. Furst, et al.. (2010). Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial. Annals of the Rheumatic Diseases. 70(1). 32–38. 322 indexed citations
14.
Merkel, Peter A., Nancy Silliman, Christopher P. Denton, et al.. (2008). Validity, reliability, and feasibility of durometer measurements of scleroderma skin disease in a multicenter treatment trial. Arthritis Care & Research. 59(5). 699–705. 80 indexed citations
15.
Khanna, Dinesh, Ron D. Hays, Grace S. Park, et al.. (2007). Development of a preliminary scleroderma gastrointestinal tract 1.0 quality of life instrument. Arthritis Care & Research. 57(7). 1280–1286. 57 indexed citations
16.
Denton, Christopher P., Peter A. Merkel, Daniel E. Furst, et al.. (2006). Recombinant human anti–transforming growth factor β1 antibody therapy in systemic sclerosis: A multicenter, randomized, placebo‐controlled phase I/II trial of CAT‐192. Arthritis & Rheumatism. 56(1). 323–333. 353 indexed citations
17.
Hsu, Vivien, et al.. (2006). P-wave amplitude and pulmonary artery pressure in scleroderma. Journal of Electrocardiology. 39(4). 385–388. 7 indexed citations
18.
Taylor, Matthew, Todd Grand, Jeffrey Е. Cohen, et al.. (2005). Ethyl Pyruvate Enhances ATP Levels, Reduces Oxidative Stress and Preserves Cardiac Function in a Rat Model of Off-Pump Coronary Bypass. Heart Lung and Circulation. 14(1). 25–31. 22 indexed citations
19.
Seibold, James R., Joseph H. Korn, Robert W. Simms, et al.. (2000). Recombinant Human Relaxin in the Treatment of Scleroderma. Annals of Internal Medicine. 44 indexed citations
20.
Hsu, Vivien, Sondra J. Patella, & Leonard H. Sigal. (1993). “Chronic lyme disease” as the incorrect diagnosis in patients with fibromyalgia. Arthritis & Rheumatism. 36(11). 1493–1500. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026